1 year return (CAGR)
-83.00%
Atrium Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
RNA
7.99
+0.02 (+0.25%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
7.79%
5 year return (CAGR)
-19.28%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
136.67M
Price/Sales
3.80
Ent value
129.97M
Price/Book
0.64
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
19.41%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 8.00 |
| Daily high | 8.07 |
| Daily low | 7.78 |
| Daily Volume | 233K |
| All-time high | 72.93 |
| 1y analyst estimate | 25.00 |
| Beta | 0.93 |
| EPS (TTM) | -15.16 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RNA | S&P500 | |
| Current price drop from All-time high | -89.04% | -1.79% |
| Highest price drop | -89.25% | -56.47% |
| Date of highest drop | 2 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -42.04% | -10.67% |
| Avg time to new high | 32 days | 12 days |
| Max time to new high | 942 days | 1805 days |
News
